Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis

BACKGROUND: Rasagiline is a selective, irreversible monoamine oxidase type B inhibitor used as monotherapy in early Parkinson's disease and as an adjunct therapy to levodopa in Parkinson's disease with motor fluctuations. OBJECTIVES: This meta-analysis aimed to provide updated evidence on...

Descripción completa

Detalles Bibliográficos
Autores principales: Kano, Osamu, Tsuda, Hiroshi, Hayashi, Ayako, Arai, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448622/
https://www.ncbi.nlm.nih.gov/pubmed/36081594
http://dx.doi.org/10.1155/2022/4216452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448622/
https://www.ncbi.nlm.nih.gov/pubmed/36081594
http://dx.doi.org/10.1155/2022/4216452

Ejemplares similares